Skip to main content
JANX logo
JANX
(NASDAQ)
Janux Therapeutics, Inc.
$18.60-- (--)
Loading... - Market loading

Janux Therapeutics (JANX) Stock Price & Financial Analysis

Janux Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$17.50 - $19.03
52-Week High$35.34
52-Week Low$12.12
Open$17.82
Volume1.45M
Average Volume (3M)742.40K
Market Cap1.17B
Shares Outstanding62.67M
Price to Sales (P/S)47.14
Price to Book (P/B)1.08
EV/EBITDA-7.99
Revenue (TTM)21.61M
Net Income (TTM)-114.48M
Free Cash Flow (TTM)-78.49M
EPS (TTM)$-1.84
Profit Margin-529.67%
Operating Margin-726.34%
Return on Equity (ROE)-12.16%
Debt to Equity0.02
50-Day MA$15.30
200-Day MA$16.25
52-Week Change-35.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Janux Therapeutics

What is the current stock price for JANX?

As of the latest trading session, JANX stock trades at $18.60. The 52-week range is $12.12–$35.34, with a day range of $17.50–$19.02.

What is the P/E ratio for JANX?

The P/E ratio (Price-to-Earnings) for JANX is shown in the Key Statistics section. This valuation metric helps compare Janux Therapeutics, Inc. to industry peers.

Does JANX pay dividends?

Janux Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for JANX?

Based on 1 analyst, the consensus for JANX is Buy.

What is the market cap of JANX?

Janux Therapeutics's market capitalization is $1.17B, classifying it as a small-cap company. Janux Therapeutics operates in the Healthcare sector within the Biotechnology industry.